Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...

A non–peer-reviewed study published on the preprint server bioRxiv suggests that highly pathogenic avian influenza (HPAI) virus shed in poultry droppings can be transmitted by the wind, a possibility ...

Echoing results from earlier California investigations into H5N1 infections in domestic cats, an investigation by agriculture ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be ...

Zoetis received a conditional license from USDA for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, for use in chickens. USDA has allocated significant funding for HPAI response ...

Agriculture Secretary Brooke Rollins is expected “in the coming days” to announce a new strategy for fighting the bird flu ...

The virus is spreading with greater speed among animals, with transmission to humans increasing. But risk to the general ...

The US is reconsidering its bird flu strategy, potentially moving towards vaccination after years of culling infected flocks.

Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license ...

Zoetis on Feb. 14 received a conditional license from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus.